[HTML][HTML] Plasma 16: 0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes

D Denimal, L Duvillard, S Béland-Bonenfant… - Diabetes & …, 2024 - Elsevier
Aim New tools are required to better assess cardiovascular risk in individuals with type 2
diabetes mellitus (T2DM). Plasma ceramides emerge as promising candidates, given their …

Plasma 16: 0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes.

D Denimal, L Duvillard, S Béland-Bonenfant… - Diabetes & …, 2024 - europepmc.org
Aim New tools are required to better assess cardiovascular risk in individuals with type 2
diabetes mellitus (T2DM). Plasma ceramides emerge as promising candidates, given their …

Plasma 16: 0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes

D Denimal, L Duvillard, S Béland-Bonenfant… - Diabetes & … - pubmed.ncbi.nlm.nih.gov
Aim New tools are required to better assess cardiovascular risk in individuals with type 2
diabetes mellitus (T2DM). Plasma ceramides emerge as promising candidates, given their …